Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Immunogen (IMGN)
NASDAQ:IMGN
ImmunoGen (IMGN) Stock Price & Analysis
1,056 Followers
IMGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.10 - $6.63
Previous Close$3.93
Volume2.28M
Average Volume (3M)3.56M
Market Cap
$888.36M
Enterprise Value$628.47M
Total Cash (Recent Filing)$275.14M
Total Debt (Recent Filing)$15.24M
Price to Earnings (P/E)-4.5
Beta0.81
Next Earnings
May 05, 2023EPS Estimate
-$0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.88
Shares Outstanding220,750,928
10 Day Avg. Volume3,477,185
30 Day Avg. Volume3,561,171
Standard Deviation0.19
R-Squared0.06
Alpha-0.00005
Financial Highlights & Ratios
Price to Book (P/B)5.18
Price to Sales (P/S)13.65
Price to Cash Flow (P/CF)141.00
P/FCF Ratio-5.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.78
Enterprise Value/Gross Profit5.79
Enterprise Value/Ebitda-2.91
Forecast
1Y Price Target
$11.50Price Target Upside191.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
ImmunoGen News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMGN FAQ
What was Immunogen’s price range in the past 12 months?
Immunogen lowest stock price was $3.10 and its highest was $6.63 in the past 12 months.
What is Immunogen’s market cap?
Currently, no data Available
When is Immunogen’s upcoming earnings report date?
Immunogen’s upcoming earnings report date is May 05, 2023 which is in 44 days.
How were Immunogen’s earnings last quarter?
Immunogen released its earnings results on Mar 01, 2023. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.296 by $0.066.
Is Immunogen overvalued?
According to Wall Street analysts Immunogen’s price is currently Undervalued.
Does Immunogen pay dividends?
Immunogen does not currently pay dividends.
What is Immunogen’s EPS estimate?
Immunogen’s EPS estimate is -$0.25.
How many shares outstanding does Immunogen have?
Immunogen has 226,046,110 shares outstanding.
What happened to Immunogen’s price movement after its last earnings report?
Immunogen reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.296. Following the earnings report the stock price went up 3.608%.
Which hedge fund is a major shareholder of Immunogen?
Among the largest hedge funds holding Immunogen’s share is RA Capital Management. It holds Immunogen’s shares valued at 108M.
---
ImmunoGen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.50 (191.88% Upside)
$11.50 (191.88% Upside)
Blogger Sentiment
Bullish
IMGN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 140.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.28%
12-Months-Change
Fundamentals
Return on Equity
-92.61%
Trailing 12-Months
Asset Growth
-33.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Immunogen
ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.
---
---